Anti-CXCR4 monoclonal antibodies recognizing overlapping epitopes differ significantly in their ability to inhibit entry of human immunodeficiency virus type 1.
about
Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesConformational antibody binding to a native, cell-free expressed GPCR in block copolymer membranesi-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4.Thermal stability of the human immunodeficiency virus type 1 (HIV-1) receptors, CD4 and CXCR4, reconstituted in proteoliposomes.CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells.Therapeutic antibodies directed at G protein-coupled receptorsStructural Analysis of Chemokine Receptor-Ligand Interactions.Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CTImproved guanide compounds which bind the CXCR4 co-receptor and inhibit HIV-1 infectionSpecific interactions between the viral coreceptor CXCR4 and the biguanide-based compound NB325 mediate inhibition of human immunodeficiency virus type 1 infection.Monoclonal anti-β1-adrenergic receptor antibodies activate G protein signaling in the absence of β-arrestin recruitment.Antibody epitopes on g protein-coupled receptors mapped with genetically encoded photoactivatable cross-linkers.Rational design of CXCR4 specific antibodies with elongated CDRs.Molecular basis for the antagonistic activity of an anti-CXCR4 antibody.Detecting Cell Surface Expression of the G Protein-Coupled Receptor CXCR4.Mapping Interaction Sites on Human Chemokine Receptors by Deep Mutational Scanning.
P2860
Q26866236-DC66D8E8-9145-4F93-BE89-278278DFC816Q28543955-2955EDBC-4BE6-4D2A-82E5-913B22EE7886Q30386356-5557A5F0-D8E2-487C-9391-9BFB768C3DEFQ33725587-38E3A913-E23C-43A3-B30C-057C04F0DF0BQ34377450-929F6AE8-9964-4BDF-B1E6-A44B5E822312Q34445135-C4DA0474-B451-4F3A-887D-EB34E860B3EBQ34550666-C0ECA89C-97AD-46FF-A6B0-C526548BEEE8Q34787997-9B8CC222-1396-4A8F-A3DC-65474B8D1AEEQ36760742-A8B1922F-A569-4BD0-A828-746675535C5AQ37072116-BFF39676-14AF-4853-A73F-842192E6BD49Q37593696-2B4C2278-25BB-4298-9092-3773CC50A431Q37701720-4BB1617C-D41E-429E-BDD9-BFDD6CE3F95CQ38973911-07B2DCDE-CE63-4601-8982-736C74BBF751Q42393773-15183C25-2C49-469D-BC13-75A361A3000AQ47267404-F75C0E28-C795-4887-926C-9776C0748655Q52573419-A5211364-019B-4893-94E0-D9C7ADCDCAC0
P2860
Anti-CXCR4 monoclonal antibodies recognizing overlapping epitopes differ significantly in their ability to inhibit entry of human immunodeficiency virus type 1.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Anti-CXCR4 monoclonal antibodi ...... immunodeficiency virus type 1.
@ast
Anti-CXCR4 monoclonal antibodi ...... immunodeficiency virus type 1.
@en
type
label
Anti-CXCR4 monoclonal antibodi ...... immunodeficiency virus type 1.
@ast
Anti-CXCR4 monoclonal antibodi ...... immunodeficiency virus type 1.
@en
prefLabel
Anti-CXCR4 monoclonal antibodi ...... immunodeficiency virus type 1.
@ast
Anti-CXCR4 monoclonal antibodi ...... immunodeficiency virus type 1.
@en
P2093
P2860
P1433
P1476
Anti-CXCR4 monoclonal antibodi ...... immunodeficiency virus type 1
@en
P2093
Tatjana Dragic
Uriel Hazan
William C Olson
P2860
P304
P356
10.1128/JVI.79.3.1930-1933.2005
P577
2005-02-01T00:00:00Z